PremiumCompany AnnouncementsAstraZeneca’s Tozorakimab Delivers Third Positive Phase III Result in COPD2h agoAZN
PremiumCompany AnnouncementsAstraZeneca Expands Real‑World Evidence for Acalabrutinib in CLL2d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s Danicopan Korea Study: Real-World Data That Could Shape AZN’s Rare Disease Edge2d agoAZN
PremiumCompany AnnouncementsShell Advances Capital Return Drive with Further Multivenue Share Buy-Back3d ago